## ICE: Intercontinental Exchange Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 2.7% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($157.76)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Intercontinental Exchange (NYSE:ICE) CTO Sells 5,345 Shares**
- Source: MarketBeat | 20251211T223137 | Neutral | Relevance: 99%
-  Intercontinental Exchange (NYSE:ICE) CTO Mayur Kapani sold 5,345 shares of the company's stock on December 8th for approximately $837,401. This transaction decreased his ownership by 7.57% to 65,240 shares. The company's shares traded up $2.55 to $160.56, and analysts maintain an average "Buy" rating with a consensus target of $194.70.

**2. Rep. Richard McCormick Buys Intercontinental Exchange Inc. (NYSE:ICE) Shares**
- Source: MarketBeat | 20251211T102127 | Somewhat-Bullish | Relevance: 99%
-  Representative Richard McCormick (R-Georgia) recently purchased shares of Intercontinental Exchange Inc. (NYSE:ICE), disclosing a buy of between $1,001 and $15,000 on November 5th. This transaction was part of several stock purchases made by McCormick on the same date, including shares in Johnson & Johnson, PepsiCo, and Microsoft. The article also provides financial details for Intercontinental Exchange, including its stock performance, recent earnings, and analyst ratings, alongside insider trading activity and institutional investor holdings.

**3. Intercontinental Exchange Inc. $ICE Shares Sold by Axa S.A.**
- Source: MarketBeat | 20251209T083525 | Neutral | Relevance: 99%
-  Axa S.A. has reduced its holdings in Intercontinental Exchange Inc. (NYSE:ICE) by 3.9% in the 2nd quarter, selling 21,237 shares. Despite this, other institutional investors like Vanguard Group Inc., Geode Capital Management LLC, Norges Bank, Price T Rowe Associates Inc. MD, and Amundi have increased their stakes in ICE. Additionally, company insiders have sold shares totaling over $25 million in the last quarter, while analysts maintain a consensus "Buy" rating for the stock.

**4. Altrinsic Global Advisors LLC Cuts Stock Position in Intercontinental Exchange Inc. $ICE**
- Source: MarketBeat | 20251211T083056 | Neutral | Relevance: 99%
-  Altrinsic Global Advisors LLC significantly reduced its investment in Intercontinental Exchange Inc. (NYSE:ICE) by 31.1% in the second quarter, selling 38,314 shares and now holding 85,073 shares valued at $15.61 million. Despite this cut, other institutional investors like Advisors Capital Management LLC and Horizon Kinetics Asset Management LLC increased their positions in ICE. Additionally, insider selling activity was noted, with CEO Jeffrey C. Sprecher and SVP Douglas Foley selling substantial amounts of company stock.

**5. Intercontinental Exchange Inc. $ICE Shares Purchased by Daiwa Securities Group Inc.**
- Source: MarketBeat | 20251210T095938 | Bullish | Relevance: 99%
- Daiwa Securities Group Inc. has increased its stake in Intercontinental Exchange Inc. (NYSE:ICE) by 6.7%, now owning 104,737 shares valued at $19.2 million. This move is part of broader institutional interest, with Norges Bank and Price T Rowe Associates also significantly increasing their positions. Despite recent insider selling, analysts maintain a "Buy" rating for ICE, which reported strong Q3 earnings and revenue.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.09M) |
| Sells | 8 ($1.02M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.1%)
- Blackrock Inc.: 9.0% (+0.4%)
- State Street Corpora: 4.3% (+0.8%)
- JPMORGAN CHASE & CO: 3.0% (+109.5%)
- Morgan Stanley: 2.8% (-7.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +3.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.01 indicates undervaluation relative to growth. Forward P/E 21.8x stretched relative to 8% growth. Quality metrics strong (margin 32%). Insider selling cluster ($1.0M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $93.4B |
| Beta | 1.05 |
| 52W Range | $142.29 - $189.35 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.01 |
| Forward P/E | 21.8 |
| Current P/E | 23.6 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.7% to 2.7% (+3.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.3pp (needs >3.0% for momentum thesis). MRS_5 at 2.4% confirms short-term momentum alignment. Below SMA200 (0.96x), long-term trend not supportive. MACD histogram positive (0.90), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.68% (CS: 68) | Neutral |
| RSI_14 | 65.9 | Neutral |
| MACD Histogram | 0.90 | Bullish |
| vs SMA20 | 1.047x | Above |
| vs SMA50 | 1.052x | Above |
| vs SMA200 | 0.960x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $163.10
- **Stop Loss:** $157.76 (3.3% risk)
- **Target:** $168.44 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 258
- **Position Value:** $42,079.80
- **Portfolio %:** 42.08%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-05 (Est: $1.67)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.61 | $1.71 | +6.4% |
| 2025Q2 | $1.77 | $1.81 | +2.3% |
| 2025Q1 | $1.70 | $1.72 | +1.0% |
| 2024Q4 | $1.49 | $1.52 | +2.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*